13
Apr
2005
Alzheimer's Antibody Progress
Newsday.com reports on more progress towards the use of antibodies to attack Alzheimer's amyloid plaques: "The patients received infusions of immunoglobulin, a mix of antibodies derived from human blood donors. It was originally developed to treat children born with damaged immune systems and is now used for diseases including lupus and multiple sclerosis. ... The human antibodies in immunoglobulin destroy the sticky brain plaque called amyloid that is a hallmark of Alzheimer's. ... The benefit of the approach, called passive vaccine therapy, because it administers antibodies rather than require the body to manufacture the antibodies, is that it can be stopped at any sign of a problem."
Comments
Post a comment; thoughtful, considered opinions are valued. Please note that comments incorporating ad hominem attacks, advertising, and other forms of inappropriate behavior are likely to be deleted.